Page last updated: 2024-08-24

topotecan and Proteinuria

topotecan has been researched along with Proteinuria in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Gilkeson, GS; Helke, KL; Oates, JC; Wang, X; Zhang, XK	1

Other Studies

1 other study(ies) available for topotecan and Proteinuria

Article	Year
Camptothecin and Topotecan, Inhibitors of Transcription Factor Fli-1 and Topoisomerase, Markedly Ameliorate Lupus Nephritis in (NZB × NZW)F1 Mice and Reduce the Production of Inflammatory Mediators in Human Renal Cells. Arthritis & rheumatology (Hoboken, N.J.), 2021, Volume: 73, Issue:8 Topics: Animals; Autoantibodies; Camptothecin; Cytokines; Disease Models, Animal; Female; Humans; Inflammation Mediators; Kidney; Lupus Nephritis; Proteinuria; Proto-Oncogene Protein c-fli-1; Topoisomerase Inhibitors; Topotecan	2021

Article

Year

Camptothecin and Topotecan, Inhibitors of Transcription Factor Fli-1 and Topoisomerase, Markedly Ameliorate Lupus Nephritis in (NZB × NZW)F1 Mice and Reduce the Production of Inflammatory Mediators in Human Renal Cells.

Arthritis & rheumatology (Hoboken, N.J.), 2021, Volume: 73, Issue:8

Topics: Animals; Autoantibodies; Camptothecin; Cytokines; Disease Models, Animal; Female; Humans; Inflammation Mediators; Kidney; Lupus Nephritis; Proteinuria; Proto-Oncogene Protein c-fli-1; Topoisomerase Inhibitors; Topotecan

2021